In order to provide the most relevant content to the readers of HealthCare Business News, we're asking you to share a little information about who you are, (it takes two seconds and then you're done).
Register
GE HealthCare highlights molecular imaging and nuclear medicine offerings at SNMMI meeting
Press releases may be edited for formatting or style | June 12, 2024
Molecular Imaging
However, as the positive and exponential rise of Theranostics drives greater demand for these radioisotopes (or tracers), the limitations of traditionally used generators have created serious challenges for clinicians and limited patient access.
In response, GE HealthCare is proud to announce the development of its new MINItrace Magni,[i] designed to be a small footprint, cost effective cyclotron for reliable, in-house production of commercial PET tracers and radiometals – like Gallium-68 – through solid target technology. When produced in combination with the company’s TRACERcenter – which is designed to serve as a complete PET radiopharmacy solution – the resulting radiopharmaceuticals can help physicians identify and diagnose clinical signs across care areas – including oncology, cardiology, and neurology.[vii]
Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system, but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities.
GE HealthCare also designs its systems with accessibility and longevity in mind, recognizing that once a system is acquired for a community, it will be depended on for many years to come.
To this end, GE HealthCare is excited to broaden its Omni platform with Omni Legend 21 cm,[ii] a performance-focused PET/CT that is designed to evolve and help meet growing healthcare system demands across care areas, including: striking image quality in oncology; an ability to accommodate increasing PET amyloid imaging volume related to Alzheimer's diagnosis in neurology; and impressive imaging of a variety of cardiac tracers, including fast decay tracers and new tracers in cardiology.
These abilities are supported by the system’s innovative 21 cm digital detector designed for augmented NEMA sensitivity,[viii] in combination with deep learning reconstruction capabilities, advanced digital solutions, and enhanced workflow offerings powered by AI. As a result, Omni Legend is designed to enable clinicians reduce the dose by up to 40%[ix] while maintaining exceptional image quality. Effortless Workflow, an AI based patient Auto Positioning solution, also helps address operational and staffing shortage challenges.
Additionally, the Omni platform is scalable, allowing radiology departments and healthcare facilities to upgrade the hardware and add service lines to help meet growing demand as well as optimize clinical capabilities, ensure access to the latest technology, and accommodate evolving community needs for many years to come.